>
pdufa.bio

KT-621

Updated ยทnext FDA decision on the calendar

KT-621 is a Kymera Therapeutics, Inc. program. Its next catalyst is a Readout in Jun 2027. Every date links its source.

KYMR catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Kymera Therapeutics, Inc. (KYMR). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2027KYMR

Questions

When is KT-621's next FDA decision or readout?

The next tracked catalyst for KT-621 is a Readout in Jun 2027.

What happened at KT-621's most recent FDA decision?

No FDA decision for KT-621 is in our archive yet.

Who makes KT-621?

Kymera Therapeutics, Inc. (KYMR).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.